JP2008528475A5 - - Google Patents

Download PDF

Info

Publication number
JP2008528475A5
JP2008528475A5 JP2007551765A JP2007551765A JP2008528475A5 JP 2008528475 A5 JP2008528475 A5 JP 2008528475A5 JP 2007551765 A JP2007551765 A JP 2007551765A JP 2007551765 A JP2007551765 A JP 2007551765A JP 2008528475 A5 JP2008528475 A5 JP 2008528475A5
Authority
JP
Japan
Prior art keywords
dha
epa
fatty acid
use according
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007551765A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008528475A (ja
JP5503846B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2006/000106 external-priority patent/WO2006077495A1/en
Publication of JP2008528475A publication Critical patent/JP2008528475A/ja
Publication of JP2008528475A5 publication Critical patent/JP2008528475A5/ja
Application granted granted Critical
Publication of JP5503846B2 publication Critical patent/JP5503846B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007551765A 2005-01-24 2006-01-24 アミロイドーシス関連疾患の治療のための医療品又は食料品の製造における、ｄｈａを含有する脂肪酸組成物の使用 Expired - Fee Related JP5503846B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US64560405P 2005-01-24 2005-01-24
SE0500174-8 2005-01-24
SE0500174 2005-01-24
US60/645,604 2005-01-24
PCT/IB2006/000106 WO2006077495A1 (en) 2005-01-24 2006-01-24 Use of a fatty acid composition containing dha for the production of a medical product or a food stuff for the treatment of amyloidos-rerelated diseases

Publications (3)

Publication Number Publication Date
JP2008528475A JP2008528475A (ja) 2008-07-31
JP2008528475A5 true JP2008528475A5 (enExample) 2009-04-09
JP5503846B2 JP5503846B2 (ja) 2014-05-28

Family

ID=36692011

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007551765A Expired - Fee Related JP5503846B2 (ja) 2005-01-24 2006-01-24 アミロイドーシス関連疾患の治療のための医療品又は食料品の製造における、ｄｈａを含有する脂肪酸組成物の使用

Country Status (7)

Country Link
US (2) US20090054523A1 (enExample)
EP (1) EP1845999A4 (enExample)
JP (1) JP5503846B2 (enExample)
KR (1) KR101253696B1 (enExample)
CA (1) CA2594781A1 (enExample)
NO (1) NO343234B1 (enExample)
WO (1) WO2006077495A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8324276B2 (en) 2005-01-24 2012-12-04 Pronova Biopharma Norge As Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
EP3263101A1 (en) 2005-12-21 2018-01-03 Brudy Technology, S.L. Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage
ES2277557B1 (es) 2005-12-21 2008-07-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento del daño celular oxidativo.
KR100879816B1 (ko) 2007-05-31 2009-01-22 학교법인 일송학원 꽁치류의 가수분해물을 포함하는 허혈성 뇌혈관질환 예방또는 개선용 조성물
PT2374452T (pt) * 2008-12-05 2019-10-31 Ajinomoto Kk Composição de nutrientes
CN108324706A (zh) * 2009-02-02 2018-07-27 帝斯曼知识产权资产有限公司 改善认知功能和降低心率的方法
US9532963B2 (en) * 2009-03-09 2017-01-03 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
US20100239660A1 (en) * 2009-03-19 2010-09-23 Doughman Scott D Product and use of omega-3s matching human tissue ratios for treatment of inflammatory and other conditions
US8124574B2 (en) 2009-10-12 2012-02-28 Conopco, Inc. Mild, foaming liquid cleansers comprising low levels of fatty isethionate product and low total fatty acid and/or fatty acid soap content
US8105994B2 (en) 2010-03-31 2012-01-31 Conopco, Inc. Personal wash cleanser comprising defined alkanoyl compounds, defined fatty acyl isethionate surfactant product and skin or hair benefit agent delivered in flocs upon dilution
CN107050457A (zh) 2012-01-06 2017-08-18 翁特拉制药公司 游离酸形式的ω‑3多不饱和脂肪酸的富含dpa组合物
EP2846779A4 (en) 2012-05-07 2015-12-16 Omthera Pharmaceuticals Inc STATIN AND OMEGA-3 FATTY ACID COMPOSITIONS
KR20220010415A (ko) * 2020-07-17 2022-01-25 대봉엘에스 주식회사 불포화 지방산을 특정 함량으로 포함하는 유지 조성물 및 이의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0707487B1 (en) * 1993-06-09 2004-04-14 Martek Biosciences Corporation Methods and pharmaceutical compositions useful for treating neurological disorders
JPH07268385A (ja) * 1994-03-31 1995-10-17 Snow Brand Milk Prod Co Ltd 魚臭が低減されたカツオおよび／またはマグロ油
JPH09511533A (ja) * 1994-09-19 1997-11-18 ザ、プロクター、エンド、ギャンブル、カンパニー 顆粒状漂白組成物
JPH08143454A (ja) * 1994-11-17 1996-06-04 Kanagawa Kagaku Kenkyusho:Kk 神経成長因子産生増強剤
EP0831805A1 (en) * 1995-06-07 1998-04-01 Martek Biosciences Corporation Methods for controlling highly unsaturated fatty acid content in various tissues
US6191154B1 (en) * 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
GB9901809D0 (en) * 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
US6395778B1 (en) * 2000-01-11 2002-05-28 Omegatech, Inc. Process for making an enriched mixture of polyunsaturated fatty acid esters
US7226916B1 (en) * 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
GB0016045D0 (en) * 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
CN1380058A (zh) * 2001-04-10 2002-11-20 上海体育运动技术学院 用于促进人体自身epa、dha合成的药物
US20030077342A1 (en) * 2001-10-09 2003-04-24 Maf Group, Llc Anti-inflammatory complex containing eicosapentaenoic acid
AU2002352726A1 (en) * 2001-11-15 2003-06-10 Galileo Laboratories, Inc. Formulations and methods for treatment or amelioration of inflammatory conditions
US8324276B2 (en) * 2005-01-24 2012-12-04 Pronova Biopharma Norge As Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction

Similar Documents

Publication Publication Date Title
US11253497B2 (en) Use of derivatives of polyunsaturated fatty acids as medicaments
RU2276975C2 (ru) Терапевтические комбинации жирных кислот
CA2549103C (en) Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
CN1638753A (zh) 脂肪酸治疗效果的强化
RU2400102C2 (ru) Композиция для лечения, замедления или предотвращения у животного слабоумия, старения мозга, когнитивного нарушения, инсульта или болезни альцгеймера и ее применение (варианты)
Demarquoy et al. Biosynthesis, metabolism and function of protectins and resolvins
US20090203780A1 (en) Use of a Polyunsaturated Fatty Acid Compound
JPH07506817A (ja) 解熱鎮痛方法および光学的に純粋なｒ‐エトドラックを含有する組成物
CN103648494A (zh) 在降低氧化应激中的dha和epa
JP5575662B2 (ja) 神経変性疾患を処置するための組成物および方法
JP4575105B2 (ja) 骨芽細胞活性抑制剤
RU2120282C1 (ru) Способ лечения сочетанных аллергических поражений кожи и желудочно-кишечного тракта у детей
Эргашева et al. OMEGA-3 AND BIOCHEMICAL PROCESSES OF INFLAMMATION IN THE BODY
Demarquoy et al. Review Clinical Lipidology
Song et al. Health Beneficial Effects of Docosahexaenoic Acid: A Marine Treasure
HK1232207B (zh) 多不饱和脂肪酸的衍生物作为药物的用途